Focalpoint invests in early stage biotech and deeptech companies with an emphasis on treating CNS and psychiatric disorders.
Looking for a job? View our portfolio companies' open roles
here.
Investments include:
Focalpoint is managed by
Brom Rector and
Sam Tabone and based in Los Angeles.
Contact: hello at our domain
